Acadia Pharmaceuticals Financial Ratios
ACAD / Health Care|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Strong profit margin: 24.9%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 28.5%
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
31.9%
ROE ranks in the below average among Health Care companies
Profit Margin
36.5%
Net Income / Revenue
Asset Turnover
0.69
Revenue / Total Assets
Equity Multiplier
1.27
Total Assets / Equity
Composite: 31.9% (reported: 31.9%)
Profitability
Liquidity
Current Ratio
3.83
Quick Ratio
3.43
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.69
Inventory Turnover
0.80
Days Sales Outstanding
41 days
As of FY2025 · SEC 10-K · Updated Jul 1, 2026
Earnings Quality
Accrual Ratio
+20.4%
+14.6pp YoY
Earnings include a notable portion of accrual components.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.